Search contract descriptions, companies and agencies.
Total Committed Value of Federal Contracts
$39.2M
Recent Contract Actions
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Description |
Category |
Agency |
Signed |
Amount Committed |
| COVID-19: BLOOD AND BLOOD PRODUCTS FOR THE VASNHCS, INCLUDING CONVALESCENT COVID PLASMA (CCP) |
Medical and Surgical Instruments, Equipment and Supplies |
Department of Veterans Affairs |
May 17, 2021 |
-$26,885 |
| DO - BLOOD AND BLOOD PRODUCTS |
Medical and Surgical Instruments, Equipment and Supplies |
Department of Veterans Affairs |
April 15, 2021 |
$6,260 |
| CHARACTERIZE SEROPREVALENCE OF SARS COV-2 ANTIBODIES IN THE US POPULATION |
Biomedical R&D |
Centers for Disease Control and Prevention |
March 11, 2021 |
$11,221,162 |
| COVID BLOOD PLASMA |
Drugs and Biologicals |
Department of Veterans Affairs |
December 04, 2020 |
$0 |
| BLOOD AND BLOOD PRODUCTS |
Drugs and Biologicals |
Department of Veterans Affairs |
October 21, 2020 |
$0 |
| MOD TO ADD COVID-19 ITEMS AND ADDENDUM |
Medical and Surgical Instruments, Equipment and Supplies |
Department of Veterans Affairs |
October 01, 2020 |
$0 |
| DO - BLOOD AND BLOOD PRODUCTS |
Medical and Surgical Instruments, Equipment and Supplies |
Department of Veterans Affairs |
October 01, 2020 |
$37,112 |
| HUMAN BLOOD&BLOOD PRODUCTS |
Drugs and Biologicals |
Department of Veterans Affairs |
October 01, 2020 |
$910,000 |
| PLASMA |
Drugs and Biologicals |
Department of Veterans Affairs |
August 19, 2020 |
$825,300 |
| COVID BLOOD PLASMA |
Drugs and Biologicals |
Department of Veterans Affairs |
August 19, 2020 |
$0 |
| CHARACTERIZE SEROPREVALENCE OF SARS COV-2 ANTIBODIES IN THE US POPULATION |
Biomedical R&D |
Centers for Disease Control and Prevention |
August 12, 2020 |
$16,921,661 |
| HUMAN BLOOD&BLOOD PRODUCTS |
Drugs and Biologicals |
Department of Veterans Affairs |
July 02, 2020 |
$0 |
| COVID-19: BLOOD AND BLOOD PRODUCTS FOR THE VASNHCS, INCLUDING CONVALESCENT COVID PLASMA (CCP) |
Medical and Surgical Instruments, Equipment and Supplies |
Department of Veterans Affairs |
June 24, 2020 |
$0 |
| MODIFICATION TO ADD COVID PLASMA |
Drugs and Biologicals |
Department of Veterans Affairs |
May 19, 2020 |
$0 |
| BLOOD PRODUCTS AND RELATED SERVICES |
Drugs and Biologicals |
Department of Veterans Affairs |
May 13, 2020 |
$2,250 |
| CHARACTERIZE SEROPREVALENCE OF SARS COV-2 ANTIBODIES IN THE US POPULATION |
Biomedical R&D |
Centers for Disease Control and Prevention |
May 13, 2020 |
$4,515,130 |
| MOD TO ADD COVID-19 ITEMS AND ADDENDUM |
Medical and Surgical Instruments, Equipment and Supplies |
Department of Veterans Affairs |
May 12, 2020 |
$0 |
| HUMAN BLOOD&BLOOD PRODUCTS |
Drugs and Biologicals |
Department of Veterans Affairs |
May 04, 2020 |
$0 |
| HUMAN BLOOD&BLOOD PRODUCTS |
Drugs and Biologicals |
Department of Veterans Affairs |
May 01, 2020 |
$5,000 |
| REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES PHASE 1 |
Biomedical R&D |
National Institutes of Health |
April 21, 2020 |
$4,748,941 |
About this data
This data comes from the
Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the
procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a
90-day delay before it appears in the data.
